In Reply On behalf of our coauthors, we thank Jambusaria-Pahlajani and colleagues for their interest in and comments to our study1 and appreciate the opportunity to respond to their concerns.
In retrospect, we recognize that the phrase, “the Breuninger system gave the best results,” following our assessment of the validity of 4 staging systems for identification of patients with cutaneous squamous cell carcinoma (cSCC) at high risk for metastasis, was not accurate, particularly after performing a reanalysis of the data. In our study, we categorized patients based on available information on risk factors, but realize that some patients potentially could have been categorized in a higher risk category if more data on variables necessary for accurate staging had been available. After performing multiple imputation of missing data, the categorization of some patients changed, leading to changes in the odds ratios for metastasis in all 4 staging systems. Also, the sensitivity, specificity, correctly classified, concordance index (C index), and R2 value changed, including significant improvements for the Brigham & Women’s Hospital (BWH) system, coming on par with and in some respects even above the Breuninger system. Therefore, the reanalysis does not support our original comment that the Breuninger system gave the best results.
Roscher I, Falk RS. Incomplete Data in Cutaneous Squamous Cell Carcinoma Staging System Analysis—Reply. JAMA Dermatol. 2018;154(12):1489. doi:10.1001/jamadermatol.2018.4018
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.